Global Anti-dandruff Agent Ingredients Market

Dandruff Treatment Market

Global Dandruff Treatment Market Research Report 2021-2025

These dandruff shampoos encourage the healing of scales on your scalp. In the context of the China-US trade war and the COVID-19 epidemic, it will have a big influence on this market. Dandruff Treatment Report by Material, Application, and Geography Global Forecast to 2025 is a professional and comprehensive research report on the worlds major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Dandruff Treatment market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025.

The report firstly introduced the Dandruff Treatment basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the worlds main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc.

In the end, the report introduced a new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The major players profiled in this report include:

Arcadia Consumer Healthcare
Vyome Therapeutics

The end users/applications and product categories analysis:

On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-

General Type

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Dandruff Treatment for each application, including-


Global Dandruff Treatment Market Research Report 2021-2025


Recent Posts

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies

Stem Cell and Platelet Rich Plasma Alopecia Therapies

COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size, Status and Forecast 2020-2026t

This report focuses on the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Orange County Hair Restoration Center
Hair Sciences Center of Colorado
Anderson Center for Hair
Evolution Hair Loss Institute
Savola Aesthetic Dermatology Center
Virginia Surgical Center
Hair Transplant Institute of Miami
Colorado Surgical Center & Hair Institute

Market segment by Type, the product can be split into

Platelet Rich Plasma Injections
Stem Cell Therapy
Market segment by Application, split into
Dermatology Clinics

Market segment by Regions/Countries, this report covers

North America
Southeast Asia
Central & South America

The study objectives of this report are:

To analyze global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies status, future forecast, growth opportunity, key market and key players.
To present the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies are as follows:

History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Get the latest Market Research Reports on COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies. Industry analysis & Market Report on COVID-19 Impact on Global Stem

Cell and Platelet Rich Plasma (PRP) Alopecia Therapies is a syndicated market report, published as COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size,

Status and Forecast 2020-2026. It is a complete Research Study and Industry Analysis of COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market, to understand,

Market Demand, Growth, trends analysis and Factor Influencing market.

COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size, Status and Forecast 2020-2026


Recent Posts

Europe Shampoo Market

Europe Shampoo Market

Europe Shampoo Market – Growth, Trends, and Forecast (2020 – 2025)

The Europe Shampoo market is projected to grow at a CAGR of 4.1% during the forecast period (2020 – 2025).

– Growing awareness about hair care products through social media, magazines, and TV advertisements are encouraging consumers to purchase various hair care products especially anti-dandruff and medical shampoo.

– Rising concerns over hair related issues, growing consumer inclination towards hair maintenance, and newly formulated product launches are projected to remain prominent market trends.

Key Market Trends

Rising Popularity of Herbal Shampoo

Organic and natural products are emerging as significant product segments in the European haircare market. With rising awareness regarding scalp-related issues and hair-fall, consumers are increasingly inclining towards herbal and natural hair care solutions. With evolving consumer needs for shampoo products comprising of natural ingredients, manufacturers are continuously expanding their product portfolio. For example, in 2019,

Loreal launched a “new generation” of professional hair care products that are exclusively used in salons. These shampoos are natural, silicone-free, paraben-free, and sulfate-free formulas with 80-100% naturally-derived ingredients. The product range is formulated with real flower and plant inclusions suspended. Moreover, the consumers are looking for shampoos infused with oils, included blended formulations and pure organics, thus, providing healthy fixes for dry and damaged hair.

Germany Holds a Significant Share in the Market

German people are stifled by the high relative costs of hair treatments and a shortage of time. They are more interested in natural hair-care products. The ongoing wellness and sustainability trends in the region are driving a surging consumer interest in natural hair care products. Younger consumers, in particular, are driving interest in sustainability and eco-friendliness, while consumers across demographics and a large section of the ex-pat population are concerned about potential health risks created by the use of chemicals in products.

Furthermore, the manufacturers are leveraging online platforms optimally, by selling their products through their own websites as well as by listing the products on popular e-retailing websites, in order to improve their brand visibility and reachability of products.​

Competitive Landscape

The shampoo market is highly competitive, with the presence of various international and domestic players. The key players in the market are focusing on leveraging opportunities posed by emerging markets, to expand their product portfolio, thus, catering to consumer’s needs for various hair concerns. Some of the major players in the global shampoo market are, L’Oréal SA, Unilever PLC, The Procter & Gamble Company, Kao Corporation among others.

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– 3 months of analyst support

Europe Shampoo Market – Growth, Trends, and Forecast (2020 – 2025)


Recent Posts

Facial Hair Transplantation

Dr Bared Co-Authors Hair Transplant Surgery Textbook

Miami Plastic Surgeon Dr Anthony Bared Co-Authors Hair Transplant Surgery Textbook

Dr Anthony Bared, a highly-respected Miami board-certified plastic surgeon and hair restoration specialist, has been published in the Hair Transplant Surgery and Platelet Rich Plasma textbook by editor Linda N. Nee.

The new handbook is suited for beginners to advanced surgeons in the rapidly-emerging field of hair transplantation.

Editor Linda N. Nee selected experts in facial plastic surgery and dermatology to write chapters in the text. Dr Anthony Bared, MD, wrote Chapter 10, Techniques in Beard and Eyebrow Restoration. The book begins with the basics and leads to advanced surgical tips with cutting-edge information.

Dr Lee, Dr Bared, and the other co-authors offer surgical tips needed by clinicians and surgeons to achieve natural-looking results.

Dr Bared specializes in beard restoration, which is an emerging trend in cosmetic surgery.

Patients visit Dr Bared in Miami, FL, to seek beard transplants for various reasons, including a desire for thicker facial hair due to genetic factors, to reverse laser hair removal, or to conceal facial burns, scarring, or cleft lip repair. Female to male transgender patients may also request information on facial hair restoration for a more masculine appearance.

Dr Bared customizes each transplant to match the patient’s desired shape and density. Men seeking facial hair transplantation typically have a specific idea of how they want their beard to appear, and Dr Bared asks them to be actively involved in the design process. Male patients may require a secondary procedure depending on the size and density of the desired beard.

At his Miami practice, Dr Bared also offers his advanced skills in eyebrow restoration, a popular treatment requested by men and women to perfect the eyebrow’s shape, density, and the hair’s natural direction and angle.

Eyebrow restoration is beneficial to women experiencing thinning eyebrows caused by genetics, over-plucking, or ageing. Some forms of alopecia, such as alopecia totalis (complete absence of the eyebrow), may affect eyebrow restoration candidacy. Men often lose the lateral aspect of the eyebrow due to ageing and desire thicker eyebrows for cosmetic reasons.

Men and women can bring photos of eyebrows and use eyeliner to fill in the brow for Dr Bared to see the look they want to achieve. The patient is actively involved in the design of their eyebrows.

Facial hair transplant specialist Dr Bared is double board-certified by the American Board of Plastic and Reconstructive Surgery and the American Board of Otolaryngology.

Advanced follicular unit extraction (FUE) techniques allow patients to avoid linear scars if they wear short haircuts. Dr Bared gives his patients flexibility and fantastic results using the FUE technique. He has performed over 1000 facial hair restoration procedures at his Miami practice.

If you are interested in a beard or eyebrow restoration request a consultation with Dr Anthony Bared, MD, FACS in Miami, Florida, or visit Facial Plastic Surgery Miami.

Miami Plastic Surgeon Dr Anthony Bared Co-Authors Hair Transplant Surgery Textbook


Recent Posts

Hair Regrowth in Phase 3 Alopecia Areata

Hair Regrowth in Phase 3 Alopecia Areata

Baricitinib is First JAK-Inhibitor to Demonstrate Hair Regrowth in Phase 3 Alopecia Areata (AA) Trial

Eli Lilly and Company announced today top-line results from BRAVE-AA2, a Phase 3 study evaluating the efficacy and safety of once-daily baricitinib 2-mg and 4-mg in adults with severe alopecia areata (AA).

Both doses of baricitinib met the primary efficacy endpoint at Week 36, demonstrating a statistically significant improvement in scalp hair regrowth compared to those randomized to placebo. AA is an autoimmune disease that causes patchy hair loss on the scalp, face and sometimes on other areas of the body that can progress.

Baricitinib has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for the treatment of AA. This classification aims to expedite the development and review of drugs that are intended to treat a serious condition when preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over already available therapies on a clinically significant endpoint(s). There are currently no FDA-approved treatments for AA.

“These positive results are very promising and suggest that baricitinib has the potential to address the urgent needs of people living with alopecia areata,” said Brett King, M.D., Ph.D., associate professor of Dermatology at Yale School of Medicine. “This level of high-quality research is needed to advance our understanding and the treatment of this frequently devastating disease.”

This multicenter, randomized, double-blind, placebo-controlled study included 546 adults with a Severity of Alopecia Tool (SALT) score ≥ 50 (i.e., who had ≥50% scalp hair loss) and a current episode of severe AA lasting at least six months but no more than eight years. The study included a diverse patient population from Argentina, Australia, Brazil, China, Israel, Japan, South Korea, Taiwan and the U.S.

Safety outcomes of baricitinib in BRAVE-AA2 were consistent with its established safety profile in patients with rheumatoid arthritis (RA) and atopic dermatitis (AD). No deaths, major adverse cardiovascular events (MACE) or venous thromboembolic events (VTEs) were reported in the study.

BRAVE-AA2 is the first Phase 3 study with positive results in patients with AA. Data from an additional Phase 3 study of baricitinib in AA will be available in the first half of this year. Detailed results from the BRAVE program will be presented at an upcoming medical conference and published in a peer-reviewed journal later this year. AA is the second potential treatment indication in dermatology for baricitinib after AD.

“For patients who suffer from alopecia areata, it is not a cosmetic condition, it is a devastating autoimmune disease that can have significant psychological effects. They lose much more than just hair,” said Lotus Mallbris, M.D., Ph.D., vice president of immunology development at Lilly. “We are looking forward to sharing the totality of data from the overall clinical development program for baricitinib as a potential first-in-disease treatment for alopecia areata.”

“Significant unmet need exists in the treatment of alopecia areata,” said Abby Ellison, research director at the National Alopecia Areata Foundation (NAAF). “We appreciate Lilly’s important work in this area and are excited that these data could bring us closer to a potential new treatment option for patients.”

Baricitinib is an oral JAK inhibitor discovered by Incyte and licensed to Lilly. It is approved and commercially available as OLUMIANT in the U.S. and more than 70 countries as a treatment for adults with moderate to severe active RA and in the European Union and Japan for the treatment of adult patients with moderate to severe AD who are candidates for systemic therapy. Baricitinib is also being investigated in systematic lupus erythematosus (SLE), juvenile idiopathic arthritis (JIA) and COVID-19.

Baricitinib is First JAK-Inhibitor to Demonstrate Hair Regrowth in Phase 3 Alopecia Areata (AA) Trial


Recent Posts

Facial Hair Transplantation

Facial Hair Transplantation

Dr. Anthony Bared Takes Part in Facial Hair Transplantation

Acclaimed Miami plastic surgeon and hair transplant specialist Dr. Anthony Bared recently participated in a study conducted by PubMed, MEDLINE, and Embase databases on the topic of facial hair transplantation for transgender patients.

research was conducted by looking at studies published through April 2020 discussing facial hair transplant in transmasculine patients. The goal of the study, published by Oxford University Press (Aesthetic Surgery Journal 2021,1-10), was to review current literature around the topic of facial hair transplantation to offer best practices and recommendations for surgeons providing this life-changing procedure that is becoming increasingly popular.

By determining common threads in the medical literature, invaluable conclusions were drawn during the study that have the potential to benefit thousands of patients worldwide. The review process began by looking at literature from the databases of PubMed, Embase and MEDLINE. Data was gathered from all relevant studies through April of 2020 and broken down so that valuable meta-analysis could be conducted.

The data exported from these studies include demographics, outcomes, specific techniques, complications, side-effects and patient satisfaction. The results provided many useful conclusions that led Dr. Bared and his colleagues to create recommendations for surgeons serving transmasculine patients.

The study comes in the wake of the increasing demand for facial hair transplantation in transmasculine patients. Transmasculine patients, transgender individuals assigned female at birth but identifying as male, are a growing segment of the population seeking gender reassignment surgery. As such, research seeking to improve aesthetic factors in this group is seeing greater interest. Dr. Anthony Bared is an authority on plastic surgery and has a commitment to serving transgender patients.

Hair transplantation can play a life-changing role in the process of gender reassignment surgeries but tailoring the outcome to transmasculine patients requires greater specialization than most surgeons possess. Dr. Anthony Bared’s clinic has seen an increased influx of transgender patients seeking hair restoration in recent years. Procedures such as eyebrow transplantation, hairline lowering and pubic hair transplants are common for male-to-female patients.

On the other hand, female-to-male patients typically seek hair procedures that focus on beard and body hair. The study conducted by Dr. Bared and his colleagues provides valuable insight into the role that hair transplantation plays in the lives of transmasculine patients and maps out a surgical path to attaining optimal results.

Dr. Anthony Bared’s medical training started with Otolaryngology at the University of Miami. He was later awarded a highly competitive fellowship by the American Academy of Facial Plastic and Reconstructive Surgery. His credentials include being double board-certified by the American Board of Otolaryngology and the American Board of Facial Plastic and Reconstructive Surgery.

Dr. Bared’s office is located in Miami, FL. The doctor is recognized by patients and peers alike for his expertise in surgical and non-surgical procedures and treatments, especially hair transplantation.

Dr. Anthony Bared Takes Part in Facial Hair Transplantation


Recent Posts

Global Alopecia Treatment Market

Speaker discusses use of JAK inhibitors in alopecia

Speaker discusses use of JAK inhibitors in alopecia

A speaker at South Beach Symposium Medical Dermatology Summit discussed the JAK inhibitors that are currently on the market and their applications in treating alopecia areata.

Antonella Tosti, MD, said that JAK inhibitors “are probably the future of treatment for alopecia areata.”

Of the three main JAK inhibitors used for alopecia areata — ruxolitinib, baricitinib and tofacitinib — tofacitinib “has been most studied,” Tosti said. The standard dose of tofacitinib is 5 mg twice daily.

Patients usually regrow hair about 3 months after beginning treatment, and even though some patients may take longer, they should “persist and continue the treatment,” she said.

About 70% of patients respond to tofacitinib, although it is typically less effective in long-standing alopecia totalis or alopecia universalis. However, the oral formulation is more effective than the topical formulation, Tosti said.

Large clinical trials for ruxolitinib and baricitinib are ongoing, according to Tosti. In the literature cited during the presentation, ruxolitinib doses were 10 mg twice daily and 10 mg every other day. She also said “usually ruxolitinib causes visible regrowth earlier than tofacitinib.”

There is not yet data on long-term side effects, but patients commonly experience upper respiratory infections, headache and weight gain. Given the potential danger of upper respiratory infections during the era of COVID-19, Tosti has advised her patients to discontinue treatment if they develop COVID-19 symptoms. Other side effects, such as severe infection, have been reported among patients taking a JAK inhibitor for another indication.

Tosti said there are several JAK inhibitor compounds in the phase 2 or 3 stage of development.

Speaker discusses use of JAK inhibitors in alopecia


Recent Posts

Hair Transplant Expert Dr Epstein

Hair Transplant Expert Dr Epstein

Miami Hair Transplant Expert Dr Epstein Ranked Among the World’s Top 10 Hair Clinics

Dr. Jeffrey Epstein, M.D., FACS, FISHRS, is proud to be listed among the top ten hair restoration clinics worldwide by HairSite is a one-of-a-kind patient statistics site that focuses only on hair transplant options and features the Top 10 Hair Restoration Hall of Fame.

HairSite worldwide map has collected over 3400 patient results from approximately 80 clinics worldwide and features this information for patients looking for realistic hair transplant options. Dr. Epstein is the founder and director of the Foundation for Hair Restoration and is listed in the Hall of Fame based on 87 patient reviews over nine uninterrupted years with HairSite.

Dr. Epstein is board-certified in facial plastic surgery and otolaryngology-head and neck surgery. He is also a Diplomat of the American Board of Hair Restoration Surgery and a fellow of the American College of Surgeons (FACS) and the International Society of Hair Restoration Surgery (FISHRS).

Dr. Epstein has over 25 years of experience and has helped thousands of patients restore their confidence through hair restoration. He performs all of the procedures requested by his patients, accompanied by a full-time staff of 10 expert assistants, including three nurse practitioners.

Dr. Epstein stays on top of cutting-edge research, including fat transfer and stem cell technology. He also educates the next generation of surgeons through his articles and lectures and serves as editor of the Hair Transplant Forum International, composed of more than 1200 surgeons worldwide.

Patients travel from around the world to visit Dr. Epstein. He has been performing hair restoration procedures since 1994 and has a loyal following with patients from over 80 countries and all 50 states. Dr. Epstein is a highly-qualified facial surgeon who is also recognized as one of the world’s best hair restoration surgeons.

He sees patients in Miami and NYC and provides virtual consultations by webcam for patients who want a customized hair restoration but live out of the state or the country. Although hair restoration procedures are not 100% predictable, Dr. Epstein’s patients have experienced a high success rate with an over 90% average.

Dr. Epstein is a hair restoration specialist who offers eyebrow transplants, follicular unit extraction (FUE) for thinning hair or baldness, facial hair transplants for beards, and hairline advancements to treat large foreheads or receding hairlines. Dr. Epstein is honored to be included by’s Top 10 Hair Restoration Hall of Fame based on his exceptional hair restoration results and patient satisfaction.

Miami Hair Transplant Expert Dr Epstein Ranked Among the World’s Top 10 Hair Clinics


Recent Posts

Medical Breakthrough Set to Disrupt Hair Restoration Industry

Hair Raising Lessons Learned After Gorilla Glue Girl

Hair Raising Lessons Learned After Gorilla Glue Girl Debacle

One of the nation’s leading hair restoration experts is providing answers to questions so many people asked after a Louisiana woman pled for help on social media when she coated her hair with a super-strong adhesive. Renowned hair surgeon Dr. Sara Wasserbauer is sharing her expertise on what happened to the woman’s hair and other treatments that could cause similar scary situations.

“Hair is an extremely complex organ, while it is a very resilient part of your body, it is very delicate and should always be treated that way,” explains Dr. Wasserbauer. “If you put strong glue in your hair, that glue is encasing the hair, binding all the hair together, making the hair breakable or brittle and more difficult to get the glue out.”

The Louisiana woman, Tessica Brown, became a social media sensation when she posted a story on TikTok about putting Gorilla Spray Adhesive on her head when she ran out of her usual hair spray, Got2b Glued. Brown suffered for three weeks before a Beverly Hills plastic surgeon used a medical-grade adhesive remover, aloe vera, olive oil and acetone to break down the coating of polyurethane on her hair.

“Polyurethane is among the top of the list of chemicals that should never touch a hair follicle,” says Dr. Wasserbauer. “Just like in Tessica Brown’s case, polyurethane sticks to hair and forms a hair shell. When adhesives are in the hair, you need to use a solvent, wear gloves and work on small areas at a time plus you will probably need to wash your hair multiple times.”

Not every case of damaged hair is as extreme as the Gorilla Glue case. Dr. Wasserbauer says many people damage their hair just by using a flat iron, hot comb, curling iron and hair straightening products way too much.

“Anything that can make your hair look good short term could hurt your hair long term, a big offender is the trendy Brazilian blowout,” explains Dr. Wasserbauer. “This treatment adds animal proteins to the hair. To keep those proteins from breaking down, formaldehyde, the same chemical used to preserve dead bodies is part of the treatment. Mix formaldehyde with heat and your hair is taking a hit.”

When it comes to growing healthy hair after it is damaged, Dr. Wasserbauer recommends using coconut oil because the chemical makeup is small enough to penetrate the hair shaft. She also says there are just four kinds of shampoos that will help hair grow.

  • Zinc pyrithione shampoo – This is an approved over-the-counter dandruff shampoo
  • Selenium shampoo – Commonly used to treat dandruff and some scalp infections. It can also reduce itching, flaking, irritation and redness of the scalp.
  • Coal tar shampoo – Medicated shampoo that works by causing the skin to shed dead cells from its top layer and cut down on scaling and dryness.
  • Ketoconazole shampoo – An antifungal shampoo often found near men’s hair dying products. It is good for stubborn dandruff.

“If you use one of these shampoos, you cannot just lather and rinse, “ explains the doctor. “You must leave the shampoo on your head for about five minutes for them to work. Think of it as a medicine for your scalp, instead of shampoo for your hair.” Dr. Wasserbauer also advises checking with a doctor before starting a new regimen.

About Dr. Wasserbauer, M.D., A.B.H.R.S., F.I.S.H.R.S.

Dr. Sara Wasserbauer is one of our nation’s leading hair restoration experts. In addition to her practice at three San Francisco offices, she currently serves as President on the Board of Directors for the American Board of Hair Restoration Surgeons. She also writes a monthly feature articles for the ISHRS Hair Transplant Forum International and is a frequent media source on hair loss and related treatments. For more information, visit

Hair Raising Lessons Learned After Gorilla Glue Girl Debacle


Recent Posts

HairMax Welcomes Mary Brunetti as Brand Ambassador

HairMax Welcomes Mary Brunetti as Brand Ambassador

HairMax Welcomes Mary Brunetti as Brand Ambassador to Provide Expert Guidance on Styling and Managing Multiple Causes of Thinning Hair Including Covid-19 Hair Loss

Mary is known as much for her celebrity clientele as she is for training world-class hairstylists. For nearly 20 years, Mary has implemented her unique training program at the Sally Hershberger salon in New York City, where she is the Director of Education.

Brunetti has been called upon to style the hair for many celebrities including, Bette Midler, Mariah Carey, Mariska Hargitay, Debra Messing, Eva Longoria, Carrie Underwood, Jane Krakowski, Brooke Shields, and Giada De Laurentiis, to name a few. Mary has styled hair backstage at Fashion Week for world-renowned designers such as Donna Karan, Nicole Miller, Naeem Kahn and Vivienne Westwood.

In addition, Brunetti’s work has been published in Vogue, Elle, Vanity Fair, New York magazine, Town & Country, Modern Bride, People, Mademoiselle as well as all the leading industry trade magazines including Modern Salon, American Salon and LaunchPad.

Mary maintains a clientele in her own Mary Brunetti Salon in the resort area of the Hamptons, N.Y., and continues to consult with top salons around the country on how to implement her tried and true training program.

Mary stated: “2020 brought many unexpected upheavals to the salon industry. Once we opened back up many of my clients began approaching me with their hair loss concerns, so I began looking into options.” Mary further stated, “In my research, I learned about the seven clinical studies that HairMax conducted on laser energy for hair growth, resulting in eight FDA clearances. I was wowed by science and the ongoing development of innovative technology for hair growth and hair wellness. I love the fact that as a Brand Ambassador for HairMax, I will be part of the solution that addresses a desperate situation for so many suffering from hair loss.”

“I only recommend products that I try myself, so I began using the LaserBand 82 hair growth device and saw the results. When it comes to hair growth and wellness, nothing compares to HairMax,” States Mary.

Francesca Dubsky, Director of Marketing stated: “There has been a significant uprise in reports of hair loss post-Covid-19, typically appearing 2-3 months after diagnosis. We have seen an increase in inquiries for information as to how to recognize and treat this occurrence. Mary joining us as Brand Ambassador will help educate people on how to deal with their Covid-19 related hair loss, as well as treatments for hereditary hair loss and how HairMax products can help them regrow and revitalize their hair.”

About HairMax:

Based in Boca Raton, Lexington Int’l is the pioneer and global leader in laser hair growth technology. HairMax Laser Devices are the first device on the market to receive FDA Clearance as a medical device to treat hair loss (androgenetic alopecia) and stimulate hair growth. HairMax Laser devices have been the subject of 7 clinical studies proving both efficacy and safety with an over 90% success rate. Study results have been published in 6 peer-reviewed medical journals. HairMax Laser devices have been granted 8 FDA Clearances and hold 14 medical device licenses world-wide.

HairMax Welcomes Mary Brunetti as Brand Ambassador to Provide Expert Guidance on Styling and Managing Multiple Causes of Thinning Hair Including Covid-19 Hair Loss


Recent Posts